Indivior reported 164M in EBITDA for its fiscal semester ending in March of 2026.





Ebitda Change Date
AstraZeneca USD 5.16B 510M Jun/2026
Cassava Sciences USD -11.73M 33.44M Sep/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Glaxosmithkline GBP 2.77B 1.98B Mar/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Roche Holding CHF 13.43B 744M Jun/2026
West Pharmaceutical Services USD 243.6M 17.4M Jun/2026